Cargando…
Determinants of Thyrotoxic Cardiomyopathy Recovery
The purpose was to evaluate the effect of the disease duration prior to treatment, thyroid hormones level, or both on the reversibility of dilated cardiomyopathy. Between January 2006 and December 2010, a longitudinal study with a 6 months follow-up was carried on. One hundred and seventy patients w...
Autores principales: | Oliveros-Ruiz, Lucia, Vallejo, Maite, Diez Canseco, L. Fernando, Cárdenas, Manuel, Hermosillo, J. Antonio G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780617/ https://www.ncbi.nlm.nih.gov/pubmed/24106705 http://dx.doi.org/10.1155/2013/452709 |
Ejemplares similares
-
Thyrotoxic Cardiomyopathy: State of the Art
por: Quiroz-Aldave, Juan Eduardo, et al.
Publicado: (2023) -
Thyrotoxic Atrial Fibrillation: Factors Associated with Persistence and Risk of Ischemic Stroke
por: Wong, Cheuk-Lik, et al.
Publicado: (2017) -
Evaluating the Efficacy of Primary Treatment for Graves' Disease Complicated by Thyrotoxic Periodic Paralysis
por: Chang, Rita Yuk-Kwan, et al.
Publicado: (2014) -
A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants
por: Chang, Chin-Chun, et al.
Publicado: (2013) -
Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with Graves' disease
por: Setoyama, Daiki, et al.
Publicado: (2021)